Cargando…
D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
Autores principales: | Bingham, Elijah G., Nagarkar, Purushottam, Jain, Nirbhay S., Barr, Meaghan L., Tang, Cathy, Lee, Dong, Chang, Irene, Delong, Michael, Benhaim, Prosper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125623/ http://dx.doi.org/10.1097/01.GOX.0000934624.83908.e2 |
Ejemplares similares
-
D14. Evaluation of the Relative Safety of Oncoplastic Reduction Compared to Traditional Reduction
por: Bingham, Elijah, et al.
Publicado: (2023) -
D64. Investigating Same-Day Discharge For Postmastectomy Immediate Breast Reconstruction: A National Surgical Quality Improvement Program Study
por: Bingham, Elijah G., et al.
Publicado: (2023) -
111. A Long-term Comparison of Collagenase versus Fasciectomy in the Treatment of Dupuytren’s Contracture
por: Steppe, Cyrus S., et al.
Publicado: (2023) -
Can You Go the Distance: Collagenase Clostridium histolyticum Manipulation at 1 Month after Injection
por: Pflibsen, Lacey R., et al.
Publicado: (2023) -
D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers?
por: Kuo, Shih-Chiang Edward, et al.
Publicado: (2023)